154 related articles for article (PubMed ID: 7979279)
1. Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells.
Nichterlein T; Kretschmar M; Budeanu C; Bauer J; Linss W; Hof H
Antimicrob Agents Chemother; 1994 Jul; 38(7):1501-6. PubMed ID: 7979279
[TBL] [Abstract][Full Text] [Related]
2. Clinafloxacin (CL 960) is superior to standard therapeutics in the treatment of murine listeriosis and salmonellosis.
Nichterlein T; Bornitz F; Kretschmar M; Hof H
Zentralbl Bakteriol; 1997 Oct; 286(3):401-12. PubMed ID: 9361386
[TBL] [Abstract][Full Text] [Related]
3. The ketolide antibiotic HMR 3647, a candidate substance for the treatment of systemic and intracerebral infections with Listeria monocytogenes.
Nichterlein T; Kretschmar M; Hof H
Zentralbl Bakteriol; 1999 Apr; 289(2):155-64. PubMed ID: 10360316
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes.
Cherubin CE; Stratton CW
Diagn Microbiol Infect Dis; 1994 Sep; 20(1):21-5. PubMed ID: 7867294
[TBL] [Abstract][Full Text] [Related]
5. RP 59500, a streptogramin derivative, is effective in murine listeriosis.
Nichterlein T; Kretschmar M; Hof H
J Chemother; 1996 Apr; 8(2):107-12. PubMed ID: 8708741
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon.
Ouadrhiri Y; Scorneaux B; Sibille Y; Tulkens PM
Antimicrob Agents Chemother; 1999 May; 43(5):1242-51. PubMed ID: 10223943
[TBL] [Abstract][Full Text] [Related]
7. Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice.
Bakker-Woudenberg IA; Lokerse AF; Roerdink FH; Regts D; Michel MF
J Infect Dis; 1985 May; 151(5):917-24. PubMed ID: 3921624
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental listeriosis by CI 934, a new quinolone.
Hof H
J Antimicrob Chemother; 1990 Jan; 25(1):121-6. PubMed ID: 2108112
[TBL] [Abstract][Full Text] [Related]
9. The antibacterial efficacy of trovafloxacin against an experimental infection with Listeria monocytogenes in hydrocortisone-treated mice.
van Ogtrop ML
J Antimicrob Chemother; 1999 Aug; 44(2):229-34. PubMed ID: 10473230
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic activity of teicoplanin on experimental listeriosis compared with that of vancomycin and ampicillin.
Berner R; Hof H
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 268(1):50-6. PubMed ID: 2969166
[TBL] [Abstract][Full Text] [Related]
11. Systemic and intracerebral infections of mice with Listeria monocytogenes successfully treated with linezolid.
Callapina M; Kretschmar M; Dietz A; Mosbach C; Hof H; Nichterlein T
J Chemother; 2001 Jun; 13(3):265-9. PubMed ID: 11450884
[TBL] [Abstract][Full Text] [Related]
12. Murine model for therapy of listeriosis in the compromised host. III. The effect of rifampicin.
Hof H; Emmerling P
Chemotherapy; 1984; 30(2):125-30. PubMed ID: 6199164
[TBL] [Abstract][Full Text] [Related]
13. Murine model for therapy of listeriosis in the compromised host. IV. Cotrimoxazole.
Kawaler B; Hof H
Chemotherapy; 1985; 31(5):366-71. PubMed ID: 3931993
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1.
Scorneaux B; Ouadrhiri Y; Anzalone G; Tulkens PM
Antimicrob Agents Chemother; 1996 May; 40(5):1225-30. PubMed ID: 8723471
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of murine listeriosis and salmonellosis with levofloxacin.
Nichterlein T; Bornitz F; Kretschmar M; Hof H
J Chemother; 1998 Aug; 10(4):313-9. PubMed ID: 9720471
[TBL] [Abstract][Full Text] [Related]
16. In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones against Listeria monocytogenes.
Facinelli B; Magi G; Prenna M; Ripa S; Varaldo PE
Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):827-33. PubMed ID: 9447905
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of Bay y 3118, a new quinolone.
Fass RJ
Antimicrob Agents Chemother; 1993 Nov; 37(11):2348-57. PubMed ID: 8285618
[TBL] [Abstract][Full Text] [Related]
18. Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection.
Wagner RD; Steinberg H; Brown JF; Czuprynski CJ
Microb Pathog; 1994 Sep; 17(3):175-86. PubMed ID: 7700134
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice.
Youssef M; Fattal E; Alonso MJ; Roblot-Treupel L; Sauzières J; Tancrède C; Omnès A; Couvreur P; Andremont A
Antimicrob Agents Chemother; 1988 Aug; 32(8):1204-7. PubMed ID: 3142347
[TBL] [Abstract][Full Text] [Related]
20. Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro.
Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH
Infection; 1988; 16 Suppl 2():S165-70. PubMed ID: 3138190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
